Review



mammaprint dna microarray-based test for prognosis of her2þ early breast cancers  (Agendia BV)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Agendia BV mammaprint dna microarray-based test for prognosis of her2þ early breast cancers
    Mammaprint Dna Microarray Based Test For Prognosis Of Her2þ Early Breast Cancers, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+microarray-based+breast+cancer+prognosis+test+mammaprint/pm20346697-199-14-13?v=Agendia+BV
    Average 90 stars, based on 1 article reviews
    mammaprint dna microarray-based test for prognosis of her2þ early breast cancers - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    mammaprint dna microarray-based test for prognosis of her2þ early breast cancers  (Agendia BV)
    90
    Agendia BV mammaprint dna microarray-based test for prognosis of her2þ early breast cancers
    Mammaprint Dna Microarray Based Test For Prognosis Of Her2þ Early Breast Cancers, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+microarray-based+breast+cancer+prognosis+test+mammaprint/pm20346697-199-14-13?v=Agendia+BV
    Average 90 stars, based on 1 article reviews
    mammaprint dna microarray-based test for prognosis of her2þ early breast cancers - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    dna microarray-based breast cancer prognosis test mammaprint  (Agendia BV)
    90
    Agendia BV dna microarray-based breast cancer prognosis test mammaprint
    Dna Microarray Based Breast Cancer Prognosis Test Mammaprint, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dna+microarray-based+breast+cancer+prognosis+test+mammaprint/pm18534094-68-9-10?v=Agendia+BV
    Average 90 stars, based on 1 article reviews
    dna microarray-based breast cancer prognosis test mammaprint - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results